Premium
Laparoscopic resection for recurrent Crohn’s disease: safety, feasibility and short‐term outcomes
Author(s) -
Bandyopadhyay D.,
Sagar P. M.,
Mirnezami A.,
Lengyel J.,
Morrison C.,
Gatt M.
Publication year - 2011
Publication title -
colorectal disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.029
H-Index - 89
eISSN - 1463-1318
pISSN - 1462-8910
DOI - 10.1111/j.1463-1318.2009.02100.x
Subject(s) - medicine , crohn's disease , surgery , abscess , demographics , anastomosis , resection , disease , endoscopy , demography , sociology
Aim The safety, feasibility and short‐term outcomes of laparoscopic resection were assessed in patients with recurrent ileocolic Crohn’s disease. Method A consecutive series of patients was identified from a prospectively collated database. Data included patient demographics, previous medical and surgical treatment, operative details and postoperative course. Data from the original index open operation were collected retrospectively by review of the case notes. Results Between 2005 and 2009, 27 patients [21 women, mean (range) age 31 years (16–51 years)] underwent laparoscopic resection for recurrent ileocolic Crohn’s disease. All had histologically confirmed recurrent disease at the ileocolic anastomosis. Five (18.5%) patients required extended resection for Crohn’s colitis, three (11.1%) had fistulating disease and one (3.4%) patient had a psoas abscess. The median (range) operative time was 110 min (70–170 min) with a conversion rate of two (7.4%) of 27 patients. The length of stay was 4 days (2–7 days) with time to return to work or full activity of 3.5 weeks (2–7 weeks). Conclusion Laparoscopic resection of recurrent ileocolic Crohn’s disease is safe, feasible and associated with short‐term benefits.